BI 705564 in Patients With Systemic Lupus Erythematosus (SLE)

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

March 16, 2019

Primary Completion Date

December 21, 2019

Study Completion Date

January 7, 2020

Conditions
Lupus Erythematosus, Systemic
Interventions
DRUG

BI 705564

Film-coated Tablet

DRUG

Placebo

Film-coated Tablet

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT03771885 - BI 705564 in Patients With Systemic Lupus Erythematosus (SLE) | Biotech Hunter | Biotech Hunter